Photodynamic therapy-treated choroidal neovascular membrane secondary to toxoplasmic retinochoroiditis.
OBJECTIVE
To report the result of photodynamic therapy with Visudyne (PDT) on a child with choroidal neovascular membrane (CNV) secondary to toxoplasmic retinochoroiditis.


METHODS
An 11-year-old child with a unilateral lowering of visual acuity secondary to an extrafoveal choroidal neovascular membrane was submitted to PDT.


RESULTS
One week after PDT, the patient's vision had improved from 10/160 to 20/70, with marked improvement in the angiographic findings. The CNV evolved with decreasing of leakage until 45 days after operation, when it regressed to a chorioretinal scar formation, with final vision of 20/25.


CONCLUSIONS
PDT promoted an early recovery of visual acuity in an eye with choroidal neovascularization secondary to toxoplasmic retinochoroiditis.
Oliveira
Leonardo Bruno
LB
HOBC-Hospital de Olhos Brasil Central, Rua Tapuirama 281 ap. 704, 38400-436 Uberlândia, MG, Brazil. leonardobruno@hotmail.com
Reis
Pedro Augusto
PA
D000981:Antiprotozoal Agents / Q000627:therapeutic use; D002648:Child; D002825:Chorioretinitis / Q000150:complications / Q000188:drug therapy*; D020256:Choroidal Neovascularization / Q000188:drug therapy* / Q000209:etiology; D004359:Drug Therapy, Combination; D005260:Female; D005451:Fluorescein Angiography; D006801:Humans; D008566:Membranes; D010778:Photochemotherapy; D017319:Photosensitizing Agents / Q000627:therapeutic use*; D011166:Porphyrins / Q000627:therapeutic use*; D014126:Toxoplasmosis, Ocular / Q000150:complications / Q000188:drug therapy*; D000077362:Verteporfin; D014792:Visual Acuity
D000981:Antiprotozoal Agents; D017319:Photosensitizing Agents; D011166:Porphyrins; D000077362:Verteporfin